The latest report by IMARC Group, titled" Blood Plasma Derivatives Market Size, Share, Trends and Forecast by Type, Application, End User, and Region, 2025-2033", offers a comprehensive analysis of the industry, which comprises insights on the market. The global blood plasma derivatives market size was valued at USD 48.27 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 75.9 Billion by 2033, exhibiting a CAGR of 5.2% from 2025-2033.

Factors Affecting the Growth of the Global Blood Plasma Derivatives Industry:

• Technological Advancements: 

Advancements in the development of plasma-derived products are playing a crucial role in driving the blood plasma derivatives market. Continuous research and innovation have led to the introduction of new and improved plasma-derived therapies that offer better efficacy, safety, and convenience for patients. These advancements include the development of novel formulations, extended half-life products, and new indications for existing therapies. As a result, the therapeutic applications of blood plasma derivatives are expanding, leading to increased demand. Furthermore, the ongoing investment in biopharmaceutical research and development is expected to bring forth even more innovative plasma-derived products, ensuring sustained market growth in the coming years.

• Increasing Prevalence of Autoimmune Diseases: 

The growing prevalence of autoimmune diseases and immunodeficiency disorders is significantly driving the demand for immunoglobulins, a key blood plasma derivative. Immunoglobulins are used extensively in the treatment of conditions such as chronic inflammatory demyelinating polyneuropathy (CIDP), primary immune deficiencies, and Guillain-Barre syndrome. As awareness and diagnosis of these conditions increase, so does the need for effective treatment options, leading to a higher demand for immunoglobulin therapies. The market for blood plasma derivatives benefits directly from this trend, as immunoglobulins represent a substantial segment within this market. 

• Growing Geriatric Population:

The growing geriatric population is a significant factor contributing to the expansion of the blood plasma derivatives market. Elderly individuals are more susceptible to various chronic conditions, including immune deficiencies, bleeding disorders, and neurological diseases, which require treatment with plasma-derived therapies. As the global population ages, the demand for these treatments is expected to rise substantially. The increasing prevalence of age-related health issues among the elderly population underscores the importance of blood plasma derivatives in managing these conditions, thereby driving market growth. Additionally, the aging population is more likely to require long-term care, further boosting the demand for these vital therapies.

For an in-depth analysis, you can request a sample copy of the report: https://www.imarcgroup.com/blood-plasma-derivatives-market/requestsample

Leading Companies Operating in the Global Blood Plasma Derivatives Market

• Baxter International Inc.

• Bayer AG

• CSL Limited

• Fusion Health Care Pvt. Ltd.

• Grifols S.A.

• Kedrion S.p.A.

• LFB S.A.

• Octapharma AG

• Sanofi S.A.

• Takeda Pharmaceutical Company Limited

Blood Plasma Derivatives Market Report Segmentation:

By Type: 

• Albumin

• Factor VIII

• Factor IX

• Immunoglobulin

• Hyperimmune Globulin

• Others

Immunoglobulin accounts for the largest market share due to their extensive therapeutic applications and high demand in treating a wide range of immune-related disorders.

By Application:

• Hemophilia

• Hypogammaglobulinemia

• Immunodeficiency Diseases

• Von Willebrand's Disease

• Others

Based on the application, the market has been divided into hemophilia, hypogammaglobulinemia, immunodeficiency diseases, von Willebrand’s disease, and others. 

By End User:

• Hospitals

• Clinics

• Others

Hospitals accounts for the largest market share as they are equipped with the necessary infrastructure and medical expertise to handle complex procedures, including plasma transfusions and the management of patients undergoing treatment with plasma-derived products.

Regional Insights:

• North America (United States, Canada)

• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

• Latin America (Brazil, Mexico, Others)

• Middle East and Africa

North America’s dominance in the blood plasma derivatives market is attributed to the presence of world's leading hospitals, research institutions, and biopharmaceutical companies, which facilitate the efficient collection, processing, and distribution of blood plasma derivatives.

Global Blood Plasma Derivatives Market Trends:

The increasing awareness about blood donation and the growing number of plasma collection centers globally are contributing to the market's expansion. The aging population, particularly in developed countries, is also a crucial factor, as older adults often require plasma-derived therapies. Furthermore, the growing application of plasma derivatives in various medical fields, such as neurology, oncology, and hematology, is broadening the market scope. Moreover, advancements in medical technology have led to the development of more effective and specialized plasma-derived products, further driving market growth.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.